Table 1.
Patient characteristics.
| Non-CAD (n = 11) | CAD (n = 14) | P value | |
|---|---|---|---|
| Age, yrs | 68 ± 14 | 68 ± 11 | 0.99 |
| Male/female | 4/7 | 8/6 | 0.30 |
| BMI, kg/m2 | 23.6 ± 4.2 | 24.3 ± 3.6 | 0.66 |
| Visceral abdominal fat area, cm2 | 62.1 ± 49.9 | 96.9 ± 44.0 | 0.08 |
| LVEF, % | 56 ± 16 | 50 ± 15 | 0.37 |
| CAD | |||
| 1-vessel disease | 0 (0) | 2 (14) | |
| 2-vessel disease | 0 (0) | 4 (29) | |
| 3-vessel disease | 0 (0) | 8 (57) | |
| Complications | |||
| Hypertension | 6 (55) | 10 (71) | 0.38 |
| Diabetes mellitus | 2 (18) | 11 (79) | 0.003 |
| Dyslipidemia | 2 (18) | 13 (93) | <0.001 |
| Medication | |||
| β-blocker | 4 (36) | 8 (57) | 0.30 |
| ACE inhibitor or ARB | 4 (36) | 9 (64) | 0.24 |
| Statins | 2 (18) | 14 (100) | <0.001 |
| Antidiabetics | 2 (18) | 6 (43) | 0.19 |
| HbA1c, % | 5.6 ± 0.3 | 7.2 ± 1.3 | <0.001 |
| Triglyceride, mmol/L | 1.58 ± 1.31 | 1.32 ± 0.12 | 0.63 |
| HDL-cholesterol, mmol/L | 1.47 ± 0.50 | 1.26 ± 0.29 | 0.22 |
| LDL-cholesterol, mmol/L | 2.58 ± 0.95 | 2.46 ± 0.79 | 0.75 |
| Serum adiponectin, µg/mL | 12.3 ± 5.6 | 4.6 ± 4.0 | <0.001 |
Values are mean ± SD or n (%). ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CAD, coronary artery disease; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; LVEF, left ventricular ejection fraction.